🟢 Smith & Nephew is trading 6.49% up today as Q3 revenue growth accelerated

Smith & Nephew is trading at £1,190.00, up 6.49%, after quarterly revenue growth accelerated.

• The November 4 update reported Q3 revenue growth of 3.4%, up from 1.6% in Q2; Sports Medicine & ENT grew 8%.
• Full-year revenue growth guidance was cut to around 3% from 4%, while trading profit growth guidance fell to around 4% from 8%.
• Coverage linked the positive share reaction to improving quarterly growth, despite weaker US orthopaedics and reduced guidance.